Stockwatch

Date	Sym	Company	Price	Type	Headline
2022-11-11 18:06	CC:RVX	Resverlogix Corp	0.19	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2022-11-11 18:06	CC:RVX	Resverlogix Corp	0.19	SEDAR MD & A815	SEDAR MD & A
2022-09-28 10:45	CC:RVX	Resverlogix Corp	0.205	News Release200	Resverlogix to focus apabetalone work on long COVID
2022-08-22 10:08	CC:RVX	Resverlogix Corp	0.25	News Release200	Resverlogix publishes apabetalone data in journal
2022-08-15 18:48	CC:RVX	Resverlogix Corp	0.27	News Release200	Resverlogix adds Kulikowski as chief scientific officer
2022-08-12 19:09	CC:RVX	Resverlogix Corp	0.265	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2022-08-12 19:09	CC:RVX	Resverlogix Corp	0.265	SEDAR MD & A815	SEDAR MD & A
2022-06-22 01:21	CC:RVX	Resverlogix Corp	0.26	News Release200	Resverlogix shareholders approve all AGM resolutions
2022-06-08 10:20	CC:RVX	Resverlogix Corp	0.22	News Release200	Resverlogix talks BD2-selective BET inhibitor safety
2022-05-13 18:09	CC:RVX	Resverlogix Corp	0.315	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2022-05-13 18:09	CC:RVX	Resverlogix Corp	0.315	SEDAR MD & A815	SEDAR MD & A
2022-05-09 09:43	CC:RVX	Resverlogix Corp	0.345	News Release200	Resverlogix sets FDA meeting for apabetalone study
2022-04-19 17:18	CC:RVX	Resverlogix Corp	0.44	News Release200	Resverlogix extends $6M (U.S.) debenture by one year
2022-04-01 02:43	CC:RVX	Resverlogix Corp	0.47	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2022-04-01 02:43	CC:RVX	Resverlogix Corp	0.47	SEDAR MD & A815	SEDAR MD & A
2022-04-01 02:42	CC:RVX	Resverlogix Corp	0.47	SEDAR Annual Information Form802	SEDAR Annual Information Form
2022-03-17 10:06	CC:RVX	Resverlogix Corp	0.46	News Release200	Resverlogix publishes apabetalone data in journal
2022-02-17 10:06	CC:RVX	Resverlogix Corp	0.73	News Release200	Resverlogix initiates Brazilian apabetalone trial site